This multicenter, open-label Phase II single-arm study is enrolling women with persistent or recurrent advanced ovarian, fallopian tube, and primary peritoneal epithelial cancers following at least one platinum-containing
Enzon is developing Oncaspar-IV to enhance the pharmaceutical properties of the currently available product. Oncaspar-IV utilizes an efficient modern process for manufacturing of L-asparaginase, and an improved PEG
The round was funded by two biotechnology investors – Clarus Ventures and SV Life Sciences. Adam Rosenberg, CEO of Link Medicine, said: “Link Medicine was established to bring
Idaho Technology is a privately held biotechnology company based in Salt Lake City, Utah.
The study was initiated in December 2007 and these results from the blinded study are expected in the fourth quarter of 2008. There are two pivotal PSD502 studies
The acquisition of MicroCal will allow GE Healthcare to expand its offering of technologies for the rapidly growing areas of protein science and drug discovery research, said GE.
The study is being conducted at University of California, Los Angeles by Martina Wiedau-Pazos and is designed to evaluate the safety and efficacy of AEOL 10150 in an
This trial is designed to test the efficacy, safety and tolerability of the octreotide implant in patients with acromegaly. The implant utilizes the company’s patented Hydron polymer technology
Each unit consists of one common share and one-half of one common share purchase warrant, with each whole common share purchase warrant entitling the holder to purchase one
Mr Fernandez has 12 years experience in the medical field. He has run three pulmonary rehab clinics in the Houston area and for the past six years has
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.